品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
源叶 | S42065-1mg | 1mg | 厂家现货 | 133052-90-1 |
GF109203X GF109203X |
≥99% |
|
|
源叶 | S42065-5mg | 5mg | 厂家现货 | 133052-90-1 |
GF109203X GF109203X |
≥99% |
|
|
源叶 | S42059-5g | 5g | 厂家现货 | 133052-90-1 |
(S)-1-Boc-3-氰基吡咯烷 (S)-1-Boc-3-cyanopyrrolidine |
95% |
|
|
索莱宝 | YS143189-100mg | 100mg | 厂家现货 | 133052-90-1 |
Bisindolylmaleimide I 游离态 Bisindolylmaleimide I |
98% |
|
|
索莱宝 | YS143189-50mg | 50mg | 厂家现货 | 133052-90-1 |
Bisindolylmaleimide I 游离态 Bisindolylmaleimide I |
98% |
|
|
索莱宝 | YS143189-25mg | 25mg | 厂家现货 | 133052-90-1 |
Bisindolylmaleimide I 游离态 Bisindolylmaleimide I |
98% |
|
|
索莱宝 | YS143189-5mg | 5mg | 厂家现货 | 133052-90-1 |
Bisindolylmaleimide I 游离态 Bisindolylmaleimide I |
98% |
|
|
阿拉丁 | G129390-1mg | 1mg | 现货 | 133052-90-1 |
双吲哚马来酰亚胺I GF109203X |
≥99% |
|
|
阿拉丁 | G129390-10mg | 10mg | 现货 | 133052-90-1 |
双吲哚马来酰亚胺I GF109203X |
≥99% |
|
|
阿拉丁 | G129390-50mg | 50mg | 现货 | 133052-90-1 |
双吲哚马来酰亚胺I GF109203X |
≥99% |
|
|
阿拉丁 | G129390-5mg | 5mg | 期货,请咨询 | 133052-90-1 |
双吲哚马来酰亚胺I GF109203X |
≥99% |
|
|
阿拉丁 | G421256-1ml | 1ml | 期货,请咨询 | 133052-90-1 |
双吲哚马来酰亚胺I GF109203X |
10mM in DMSO |
|
|
麦克林 | G832918-10mg | 10mg | 厂家现货 | 133052-90-1 |
双吲哚马来酰亚胺I GF109203X |
>97.0%(HPLC) |
|
|
梯希爱 | B5781-5MG | 5MG | 现货 | 133052-90-1 |
双吲哚马来酰亚胺 I Bisindolylmaleimide I |
97.0%LC |
|
|
梯希爱 | B5781-25MG | 25MG | 现货 | 133052-90-1 |
双吲哚马来酰亚胺 I Bisindolylmaleimide I |
97.0%LC |
|
|
麦克林 | G832918-5mg | 5mg | 厂家现货 | 133052-90-1 |
双吲哚马来酰亚胺I GF109203X |
>97.0%(HPLC) |
|
|
毕得 | BD117362-1mg | 1mg | 现货 | 133052-90-1 |
3-(1-(3-(二甲氨基)丙基)-1H-吲哚-3-基)... 3-(1-(3-(Dimethylamino)propy... |
98% |
|
|
毕得 | BD117362-5mg | 5mg | 现货 | 133052-90-1 |
3-(1-(3-(二甲氨基)丙基)-1H-吲哚-3-基)... 3-(1-(3-(Dimethylamino)propy... |
98% |
|
|
毕得 | BD117362-50mg | 50mg | 现货 | 133052-90-1 |
3-(1-(3-(二甲氨基)丙基)-1H-吲哚-3-基)... 3-(1-(3-(Dimethylamino)propy... |
98% |
|
|
毕得 | BD117362-100mg | 100mg | 现货 | 133052-90-1 |
3-(1-(3-(二甲氨基)丙基)-1H-吲哚-3-基)... 3-(1-(3-(Dimethylamino)propy... |
98% |
|
|